COVID-19 associated Mucormycosis: Prominent features, diagnoses, management, and treatment

Niusha Zare 1, Seyedeh Elaheh Asksri 2, Sara Mojtahedi 3 and Maryam Mohammad Alizadeh Chafjiri 4, *

1 Radiology Department, Dental Faculty of Tehran University of Medical Science Islamic Azad University, Tehran, Iran.
2 DDS, Private Practice, Huston, Texas, USA.
3 DDS, Remarkable smiles Orthodontics Irvine, CA, USA.
4 Oral and Maxillofacial Pathology, School of Dentistry, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
 
Review Article
Open Access Research Journal of Biology and Pharmacy, 2022, 05(01), 007–011.
Article DOI: 10.53022/oarjbp.2022.5.1.0042
Publication history: 
Received on 03 April 2022; revised on 12 May 2022; accepted on 14 May 2022
 
Abstract: 
COVID-19-associated infections are increasing the burden on the overall health system. Mucormycosis is also related to coronavirus 2 disease and it is termed black fungus a life-threatening fungal infection caused by mucormycosis. Mucormycosis mostly affects diabetic and immunocompromised individuals. The major aim of this study is to discuss the features of COVID-19 associated mucormycosis, diagnosis, prevention, and treatment.
 
Keywords: 
Covid-19; Mucormycosis; Diagnosis; Oral manifestation
 
Full text article in PDF: